Meunier Carlin & Curfman LLC
Compounds as BLC-2-selective apoptosis-inducing agents
Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof are provided. In particular, Bcl-2 inhibitors of formula (I) are provided, wherein the variable groups are as defined in the specification. The Bcl-2 inhibitors can be used to treat cell proliferative disorders.
Fochon Pharmaceuticals, Ltd.
A C A
A61P C07D A61K
inventional inventional inventional
Xingdong Chengxi Yue Rui Min Huajie Weibo Weipeng Lihua Zhifu Jing Zhifang Zuwen Hongbin Haohan Yanxin
Zhao He Rong Tan Lin Zhang Wang Zhang Jiang Li Sun Chen Zhou Liu Tan Liu